Information Provided By:
Fly News Breaks for December 26, 2019
Dec 26, 2019 | 12:14 EDT
Guggenheim analyst Michael Schmidt downgraded Spectrum to Neutral from Buy after poziotinib did not hit its endpoint in Cohort 1 of the ZENITH20 trial.
News For SPPI From the Last 2 Days
There are no results for your query SPPI